FLU ADENO PANEL

Flu Adeno Panel is an advanced molecular diagnostic test designed to simultaneously detect Influenza viruses and Adenovirus infections using highly sensitive PCR technology. These respiratory viruses are among the common causes of fever, cough, sore throat, breathing difficulties, and seasonal respiratory illnesses in both children and adults.

The panel enables rapid identification of viral pathogens responsible for respiratory tract infections, helping clinicians differentiate between influenza and adenovirus infections and make informed treatment and infection control decisions. Early detection is important for appropriate patient management and reducing the spread of contagious respiratory diseases.

Benefits of the Test

• Simultaneously detects Influenza and Adenovirus infections.
• Provides highly sensitive and specific molecular results.
• Supports early diagnosis of respiratory viral infections.
• Helps differentiate viral causes of respiratory symptoms.
• Assists in treatment planning and infection control.
• Reduces the need for multiple separate tests.
• Supports rapid clinical decision-making.
• Useful for both pediatric and adult patients.

Why Doctors Recommend This Test

Doctors recommend the Flu Adeno Panel for patients with fever, cough, sore throat, nasal congestion, breathing difficulties, suspected influenza, viral respiratory infections, outbreaks, and unexplained respiratory symptoms requiring accurate pathogen identification.

The test helps identify the viral cause of illness and supports appropriate medical management while avoiding unnecessary antibiotic use when viral infection is confirmed.

Preparation Before Test

• No fasting is required.
• A nasopharyngeal swab, nasal swab, or throat swab specimen is usually collected.
• Follow all instructions provided by healthcare professionals.
• Inform your doctor about current symptoms and medications.
• Provide recent travel or exposure history if applicable.
• Ensure timely specimen collection after symptom onset whenever possible.

Normal Reporting Time

Most Flu Adeno Panel reports at Focus Diagnostics are available within 2–3 hours for specimen processing and molecular workflow initiation. Final PCR analysis and reporting are generally completed within a few working days depending on laboratory workflow and quality assurance procedures.

Who Should Take This Test?

This test may be recommended for:

• Individuals with flu-like symptoms.
• Patients with respiratory tract infections.
• Children with viral respiratory illness.
• Adults with fever and cough.
• Hospitalized patients with respiratory symptoms.
• Immunocompromised individuals.
• Patients during influenza outbreaks.
• People requiring viral respiratory pathogen identification.

Detailed Information

Influenza viruses and adenoviruses are common causes of respiratory infections worldwide. Influenza infections can cause seasonal outbreaks and range from mild illness to severe pneumonia, particularly in elderly individuals, young children, pregnant women, and patients with chronic medical conditions. Adenoviruses are also important respiratory pathogens and may cause upper respiratory tract infections, pneumonia, conjunctivitis, and other systemic illnesses.

Because the symptoms of influenza and adenovirus infection often overlap, clinical diagnosis alone may not accurately determine the underlying cause. Molecular testing allows direct detection of viral genetic material and provides highly accurate pathogen identification.

The Flu Adeno Panel uses advanced multiplex Polymerase Chain Reaction (PCR) technology to simultaneously detect multiple respiratory viral targets from a single patient specimen. This approach improves diagnostic efficiency, reduces turnaround time, and minimizes the need for multiple separate tests.

Early identification of respiratory viruses helps clinicians make informed decisions regarding antiviral therapy, patient isolation, infection prevention measures, and supportive treatment strategies. It also helps distinguish viral infections from bacterial illnesses, reducing unnecessary antibiotic exposure.

The panel is particularly valuable during seasonal influenza outbreaks, respiratory infection clusters, and hospital-based surveillance programs. It is widely used for both outpatient and inpatient respiratory infection evaluation.

Results should always be interpreted in conjunction with clinical findings, patient history, physical examination, imaging studies, and additional laboratory investigations when necessary. Negative results do not completely exclude infection if testing is performed very early or late in the disease course.

At Focus Diagnostics, Flu Adeno Panel testing is performed using advanced molecular diagnostic platforms, validated multiplex PCR technology, and stringent quality assurance standards to provide accurate, reliable, and clinically meaningful respiratory infection diagnostic results.